| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 247 | 2021 | 11229 | 5.830 |
Why?
|
| Diet | 164 | 2025 | 8090 | 3.340 |
Why?
|
| Coronary Disease | 132 | 2022 | 5919 | 3.030 |
Why?
|
| Homocysteine | 37 | 2012 | 637 | 2.700 |
Why?
|
| Alcohol Drinking | 118 | 2022 | 4045 | 2.690 |
Why?
|
| Folic Acid | 52 | 2021 | 1336 | 2.660 |
Why?
|
| Prospective Studies | 601 | 2025 | 54950 | 2.580 |
Why?
|
| Estrogen Replacement Therapy | 47 | 2018 | 1209 | 2.490 |
Why?
|
| Dietary Fats | 72 | 2024 | 2003 | 2.430 |
Why?
|
| Risk Factors | 622 | 2025 | 74971 | 2.210 |
Why?
|
| Cardiovascular Diseases | 112 | 2024 | 15662 | 2.050 |
Why?
|
| Body Mass Index | 171 | 2024 | 13054 | 1.810 |
Why?
|
| Carotenoids | 43 | 2015 | 620 | 1.790 |
Why?
|
| Middle Aged | 906 | 2025 | 223740 | 1.750 |
Why?
|
| Prostate-Specific Antigen | 43 | 2020 | 2487 | 1.720 |
Why?
|
| Postmenopause | 43 | 2020 | 2519 | 1.700 |
Why?
|
| Smoking | 140 | 2020 | 9094 | 1.650 |
Why?
|
| Follow-Up Studies | 296 | 2025 | 39394 | 1.590 |
Why?
|
| Nurses | 70 | 2020 | 2501 | 1.550 |
Why?
|
| Case-Control Studies | 226 | 2024 | 22294 | 1.520 |
Why?
|
| Kidney Calculi | 19 | 2010 | 469 | 1.490 |
Why?
|
| Obesity | 84 | 2023 | 13087 | 1.460 |
Why?
|
| Myocardial Infarction | 93 | 2021 | 11521 | 1.430 |
Why?
|
| Aged | 584 | 2025 | 171790 | 1.430 |
Why?
|
| Humans | 1222 | 2025 | 768887 | 1.410 |
Why?
|
| Glioma | 16 | 2021 | 3532 | 1.410 |
Why?
|
| Adult | 764 | 2025 | 223818 | 1.400 |
Why?
|
| Proportional Hazards Models | 134 | 2024 | 12563 | 1.370 |
Why?
|
| Cohort Studies | 305 | 2025 | 41800 | 1.360 |
Why?
|
| Risk | 170 | 2021 | 9621 | 1.360 |
Why?
|
| Aspirin | 49 | 2018 | 3135 | 1.350 |
Why?
|
| Weight Loss | 26 | 2022 | 2720 | 1.330 |
Why?
|
| Male | 706 | 2025 | 365249 | 1.320 |
Why?
|
| Menopause | 41 | 2022 | 1656 | 1.310 |
Why?
|
| Feeding Behavior | 53 | 2021 | 3206 | 1.310 |
Why?
|
| Polymorphism, Genetic | 47 | 2011 | 4251 | 1.300 |
Why?
|
| Life Style | 54 | 2024 | 3931 | 1.300 |
Why?
|
| Vitamins | 27 | 2021 | 1638 | 1.280 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 22 | 2021 | 415 | 1.270 |
Why?
|
| Antioxidants | 29 | 2014 | 1673 | 1.270 |
Why?
|
| Contraceptives, Oral | 25 | 2022 | 560 | 1.260 |
Why?
|
| Pituitary Neoplasms | 3 | 2022 | 1326 | 1.250 |
Why?
|
| Vitamin E | 37 | 2015 | 874 | 1.240 |
Why?
|
| Incidence | 212 | 2024 | 21545 | 1.210 |
Why?
|
| Insulin-Like Growth Factor I | 24 | 2021 | 1942 | 1.180 |
Why?
|
| Diet, Mediterranean | 20 | 2024 | 748 | 1.170 |
Why?
|
| Nutritive Value | 4 | 2021 | 351 | 1.160 |
Why?
|
| Colorectal Neoplasms | 53 | 2024 | 6982 | 1.150 |
Why?
|
| Coffee | 15 | 2022 | 594 | 1.140 |
Why?
|
| Hormone Replacement Therapy | 12 | 2017 | 756 | 1.130 |
Why?
|
| Female | 696 | 2025 | 397464 | 1.110 |
Why?
|
| Polymorphism, Single Nucleotide | 68 | 2024 | 16051 | 1.100 |
Why?
|
| Health Personnel | 46 | 2021 | 3382 | 1.090 |
Why?
|
| Vitamin B Complex | 7 | 2017 | 299 | 1.080 |
Why?
|
| United States | 319 | 2025 | 73180 | 1.080 |
Why?
|
| Dietary Supplements | 29 | 2018 | 3442 | 1.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 76 | 2024 | 12252 | 1.050 |
Why?
|
| Adenoma | 18 | 2022 | 2164 | 1.040 |
Why?
|
| Exercise | 68 | 2022 | 5953 | 1.010 |
Why?
|
| Pancreatic Neoplasms | 29 | 2023 | 5443 | 1.010 |
Why?
|
| Longevity | 8 | 2024 | 1077 | 1.010 |
Why?
|
| Selenium | 25 | 2016 | 418 | 1.000 |
Why?
|
| Meat | 29 | 2017 | 588 | 0.980 |
Why?
|
| Breast Neoplasms | 99 | 2020 | 21187 | 0.980 |
Why?
|
| Vitamin D | 30 | 2019 | 3311 | 0.980 |
Why?
|
| Dairy Products | 21 | 2020 | 490 | 0.970 |
Why?
|
| Diet Surveys | 44 | 2024 | 1160 | 0.960 |
Why?
|
| Odds Ratio | 89 | 2022 | 9682 | 0.940 |
Why?
|
| Multivariate Analysis | 137 | 2020 | 12093 | 0.940 |
Why?
|
| Fatty Acids | 23 | 2024 | 1812 | 0.890 |
Why?
|
| Body Constitution | 12 | 2021 | 273 | 0.890 |
Why?
|
| Vegetables | 27 | 2021 | 1199 | 0.860 |
Why?
|
| Health Behavior | 19 | 2016 | 2649 | 0.850 |
Why?
|
| Calcium, Dietary | 20 | 2010 | 533 | 0.830 |
Why?
|
| Eggs | 9 | 2020 | 182 | 0.820 |
Why?
|
| Gonadal Steroid Hormones | 12 | 2017 | 708 | 0.820 |
Why?
|
| Nuts | 11 | 2017 | 264 | 0.820 |
Why?
|
| Vitamin B 6 | 10 | 2018 | 237 | 0.810 |
Why?
|
| Dietary Carbohydrates | 19 | 2019 | 896 | 0.810 |
Why?
|
| Hypertension | 59 | 2018 | 8615 | 0.810 |
Why?
|
| Risk Assessment | 98 | 2022 | 24330 | 0.790 |
Why?
|
| C-Peptide | 7 | 2024 | 443 | 0.790 |
Why?
|
| Stroke | 39 | 2022 | 9756 | 0.790 |
Why?
|
| Nutrition Policy | 13 | 2018 | 467 | 0.780 |
Why?
|
| Fruit | 23 | 2021 | 1165 | 0.770 |
Why?
|
| Lipids | 19 | 2024 | 3345 | 0.760 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2019 | 3253 | 0.750 |
Why?
|
| Pyridoxine | 11 | 2009 | 109 | 0.750 |
Why?
|
| Weight Gain | 22 | 2020 | 2359 | 0.740 |
Why?
|
| Dietary Proteins | 22 | 2021 | 960 | 0.730 |
Why?
|
| Genetic Predisposition to Disease | 59 | 2021 | 18065 | 0.730 |
Why?
|
| Vitamin B 12 | 16 | 2011 | 528 | 0.730 |
Why?
|
| beta Carotene | 35 | 2015 | 523 | 0.720 |
Why?
|
| Prostate | 15 | 2018 | 1781 | 0.720 |
Why?
|
| Energy Intake | 46 | 2022 | 2146 | 0.700 |
Why?
|
| Seafood | 11 | 2019 | 395 | 0.690 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2020 | 1040 | 0.690 |
Why?
|
| Dietary Fats, Unsaturated | 13 | 2016 | 223 | 0.690 |
Why?
|
| Diet Records | 21 | 2024 | 426 | 0.690 |
Why?
|
| Vasectomy | 3 | 2017 | 52 | 0.680 |
Why?
|
| Wine | 10 | 2016 | 172 | 0.680 |
Why?
|
| C-Reactive Protein | 27 | 2024 | 3858 | 0.670 |
Why?
|
| Ascorbic Acid | 16 | 2015 | 658 | 0.670 |
Why?
|
| Tea | 3 | 2019 | 289 | 0.660 |
Why?
|
| Aged, 80 and over | 165 | 2023 | 59738 | 0.660 |
Why?
|
| Diet, Fat-Restricted | 10 | 2017 | 328 | 0.660 |
Why?
|
| Hyperlipidemias | 4 | 2019 | 773 | 0.650 |
Why?
|
| Progestins | 12 | 2002 | 302 | 0.650 |
Why?
|
| Folic Acid Deficiency | 4 | 2016 | 117 | 0.650 |
Why?
|
| Women's Health | 22 | 2017 | 2081 | 0.640 |
Why?
|
| Cerebrovascular Disorders | 28 | 1999 | 1486 | 0.640 |
Why?
|
| Epidemiologic Studies | 12 | 2023 | 677 | 0.620 |
Why?
|
| Estrogens | 21 | 2008 | 1537 | 0.620 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 10 | 2012 | 276 | 0.620 |
Why?
|
| Alcoholic Beverages | 12 | 2021 | 266 | 0.620 |
Why?
|
| Dietary Fiber | 29 | 2010 | 767 | 0.620 |
Why?
|
| Brain Neoplasms | 12 | 2021 | 9213 | 0.620 |
Why?
|
| Mortality | 19 | 2024 | 2915 | 0.610 |
Why?
|
| Somatotypes | 1 | 2018 | 40 | 0.610 |
Why?
|
| Menarche | 13 | 2024 | 538 | 0.610 |
Why?
|
| Genotype | 69 | 2017 | 13048 | 0.610 |
Why?
|
| Neoplasms | 60 | 2023 | 22390 | 0.600 |
Why?
|
| Nails | 16 | 2017 | 298 | 0.600 |
Why?
|
| Diet, Reducing | 7 | 2017 | 487 | 0.600 |
Why?
|
| Logistic Models | 83 | 2024 | 13317 | 0.590 |
Why?
|
| Cause of Death | 29 | 2024 | 3721 | 0.590 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 16 | 2017 | 2277 | 0.590 |
Why?
|
| Body Size | 2 | 2018 | 463 | 0.590 |
Why?
|
| Vitamin A | 24 | 2017 | 611 | 0.580 |
Why?
|
| ABO Blood-Group System | 2 | 2017 | 381 | 0.570 |
Why?
|
| Triglycerides | 16 | 2021 | 2464 | 0.570 |
Why?
|
| Trans Fatty Acids | 5 | 2010 | 155 | 0.570 |
Why?
|
| Abdominal Fat | 5 | 2017 | 221 | 0.560 |
Why?
|
| Diet, Carbohydrate-Restricted | 11 | 2017 | 263 | 0.560 |
Why?
|
| Randomized Controlled Trials as Topic | 37 | 2019 | 10397 | 0.550 |
Why?
|
| Cholesterol, HDL | 28 | 2015 | 1820 | 0.550 |
Why?
|
| Milk | 6 | 2017 | 440 | 0.540 |
Why?
|
| Anthropometry | 17 | 2021 | 1343 | 0.530 |
Why?
|
| Fatty Acids, Omega-3 | 18 | 2016 | 1399 | 0.530 |
Why?
|
| Acetaminophen | 9 | 2011 | 556 | 0.530 |
Why?
|
| Cholesterol | 23 | 2021 | 2913 | 0.530 |
Why?
|
| Risk Reduction Behavior | 9 | 2021 | 1119 | 0.520 |
Why?
|
| Food | 7 | 2024 | 768 | 0.520 |
Why?
|
| Age Factors | 88 | 2021 | 18454 | 0.520 |
Why?
|
| Analgesics, Non-Narcotic | 6 | 2005 | 371 | 0.520 |
Why?
|
| Adipose Tissue | 18 | 2017 | 3335 | 0.520 |
Why?
|
| Metformin | 2 | 2014 | 909 | 0.510 |
Why?
|
| Confidence Intervals | 40 | 2021 | 2931 | 0.490 |
Why?
|
| Cholelithiasis | 10 | 2002 | 408 | 0.490 |
Why?
|
| Adiposity | 11 | 2024 | 1895 | 0.490 |
Why?
|
| Age of Onset | 8 | 2024 | 3346 | 0.490 |
Why?
|
| Chronic Disease | 16 | 2018 | 9384 | 0.480 |
Why?
|
| Anticarcinogenic Agents | 8 | 2017 | 251 | 0.470 |
Why?
|
| Disease Progression | 39 | 2018 | 13677 | 0.470 |
Why?
|
| Contraceptives, Oral, Hormonal | 6 | 2010 | 190 | 0.460 |
Why?
|
| Estrogens, Conjugated (USP) | 9 | 2018 | 277 | 0.460 |
Why?
|
| Obesity, Abdominal | 6 | 2017 | 375 | 0.450 |
Why?
|
| alpha-Linolenic Acid | 10 | 2018 | 144 | 0.450 |
Why?
|
| Time Factors | 86 | 2021 | 40266 | 0.440 |
Why?
|
| PTEN Phosphohydrolase | 8 | 2021 | 1120 | 0.440 |
Why?
|
| Basal Metabolism | 3 | 2016 | 163 | 0.440 |
Why?
|
| Minerals | 2 | 2007 | 282 | 0.430 |
Why?
|
| Adenocarcinoma | 13 | 2018 | 6401 | 0.430 |
Why?
|
| Sleep Apnea, Obstructive | 6 | 2022 | 1898 | 0.430 |
Why?
|
| Motor Activity | 8 | 2015 | 2722 | 0.420 |
Why?
|
| Enalapril | 1 | 2015 | 317 | 0.420 |
Why?
|
| Genetic Variation | 20 | 2019 | 6610 | 0.420 |
Why?
|
| Trace Elements | 4 | 2014 | 193 | 0.420 |
Why?
|
| Physicians | 34 | 2017 | 4607 | 0.420 |
Why?
|
| Body Weight | 43 | 2019 | 4628 | 0.410 |
Why?
|
| Primary Prevention | 5 | 2007 | 1187 | 0.410 |
Why?
|
| Prostatic Hyperplasia | 11 | 2014 | 523 | 0.410 |
Why?
|
| Blood Glucose | 18 | 2021 | 6434 | 0.400 |
Why?
|
| Beverages | 8 | 2018 | 819 | 0.400 |
Why?
|
| Body Height | 18 | 2022 | 1568 | 0.400 |
Why?
|
| Welding | 2 | 2010 | 89 | 0.390 |
Why?
|
| Diabetes Mellitus | 24 | 2022 | 5892 | 0.380 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 590 | 0.380 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2013 | 241 | 0.380 |
Why?
|
| Observation | 4 | 2008 | 311 | 0.380 |
Why?
|
| Nutritional Physiological Phenomena | 8 | 2019 | 360 | 0.370 |
Why?
|
| Death, Sudden, Cardiac | 13 | 2011 | 1568 | 0.370 |
Why?
|
| Health Status Indicators | 1 | 2016 | 971 | 0.360 |
Why?
|
| Citrus | 3 | 2024 | 49 | 0.360 |
Why?
|
| Tooth Loss | 3 | 2016 | 200 | 0.360 |
Why?
|
| Cognition | 10 | 2025 | 7080 | 0.360 |
Why?
|
| Workplace | 3 | 2016 | 873 | 0.360 |
Why?
|
| Genome-Wide Association Study | 27 | 2024 | 12798 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2019 | 8664 | 0.350 |
Why?
|
| Early Detection of Cancer | 5 | 2018 | 3238 | 0.350 |
Why?
|
| alpha-Tocopherol | 5 | 2017 | 127 | 0.350 |
Why?
|
| Occupational Exposure | 3 | 2010 | 1807 | 0.350 |
Why?
|
| Stromal Cells | 4 | 2017 | 1337 | 0.350 |
Why?
|
| Models, Genetic | 2 | 2020 | 3446 | 0.350 |
Why?
|
| Food, Fortified | 5 | 2015 | 189 | 0.350 |
Why?
|
| Health Surveys | 27 | 2020 | 4055 | 0.350 |
Why?
|
| Gene Expression Profiling | 13 | 2017 | 9549 | 0.350 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 5 | 2016 | 348 | 0.340 |
Why?
|
| Nutrition Surveys | 22 | 2022 | 1738 | 0.340 |
Why?
|
| Survival Analysis | 26 | 2019 | 10115 | 0.340 |
Why?
|
| Aging | 20 | 2021 | 8765 | 0.340 |
Why?
|
| Meat Products | 3 | 2015 | 97 | 0.340 |
Why?
|
| Neoplasm Staging | 38 | 2021 | 11262 | 0.340 |
Why?
|
| Self Report | 12 | 2022 | 3773 | 0.340 |
Why?
|
| Snoring | 3 | 2002 | 211 | 0.340 |
Why?
|
| Life Expectancy | 3 | 2024 | 1249 | 0.340 |
Why?
|
| Birth Weight | 9 | 2014 | 2108 | 0.330 |
Why?
|
| Food Industry | 1 | 2010 | 68 | 0.330 |
Why?
|
| Prognosis | 44 | 2020 | 30044 | 0.330 |
Why?
|
| Environment | 3 | 2022 | 1125 | 0.330 |
Why?
|
| Beer | 8 | 2014 | 135 | 0.320 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 3 | 2009 | 74 | 0.320 |
Why?
|
| Health Occupations | 8 | 2019 | 225 | 0.320 |
Why?
|
| Hair Dyes | 3 | 2020 | 30 | 0.320 |
Why?
|
| Prostatectomy | 15 | 2020 | 1841 | 0.320 |
Why?
|
| Kallikreins | 3 | 2020 | 219 | 0.310 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2018 | 2813 | 0.310 |
Why?
|
| Cholecystectomy | 7 | 2005 | 409 | 0.310 |
Why?
|
| Colonic Neoplasms | 16 | 2018 | 2543 | 0.310 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.310 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 5 | 2002 | 62 | 0.310 |
Why?
|
| Insulin | 13 | 2017 | 6610 | 0.310 |
Why?
|
| Alleles | 25 | 2021 | 6901 | 0.310 |
Why?
|
| Apolipoproteins E | 6 | 2010 | 1461 | 0.300 |
Why?
|
| Europe | 14 | 2022 | 3441 | 0.300 |
Why?
|
| Fatty Acids, Unsaturated | 10 | 2016 | 542 | 0.300 |
Why?
|
| Waist Circumference | 9 | 2024 | 935 | 0.300 |
Why?
|
| Apolipoprotein A-I | 5 | 2011 | 305 | 0.300 |
Why?
|
| Public Health | 4 | 2020 | 2680 | 0.300 |
Why?
|
| Ovarian Neoplasms | 13 | 2020 | 4919 | 0.300 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 316 | 0.290 |
Why?
|
| Puberty | 2 | 2024 | 501 | 0.290 |
Why?
|
| Lung Neoplasms | 19 | 2020 | 13593 | 0.290 |
Why?
|
| Tocopherols | 2 | 2004 | 44 | 0.290 |
Why?
|
| Regression Analysis | 37 | 2010 | 6346 | 0.290 |
Why?
|
| Blood Pressure | 31 | 2016 | 8541 | 0.290 |
Why?
|
| Health Promotion | 4 | 2016 | 2210 | 0.290 |
Why?
|
| Disabled Persons | 2 | 2016 | 1210 | 0.290 |
Why?
|
| Apolipoproteins C | 2 | 2004 | 59 | 0.280 |
Why?
|
| Manganese | 1 | 2010 | 394 | 0.280 |
Why?
|
| Gene Frequency | 10 | 2024 | 3625 | 0.280 |
Why?
|
| Meta-Analysis as Topic | 10 | 2016 | 1364 | 0.280 |
Why?
|
| Ethanol | 11 | 2015 | 1332 | 0.280 |
Why?
|
| Clinical Trials as Topic | 16 | 2018 | 8055 | 0.280 |
Why?
|
| Interleukin-6 | 11 | 2024 | 3233 | 0.280 |
Why?
|
| Parity | 17 | 2003 | 930 | 0.280 |
Why?
|
| Food-Drug Interactions | 1 | 2007 | 26 | 0.280 |
Why?
|
| Leptin | 7 | 2016 | 1597 | 0.280 |
Why?
|
| Fishes | 11 | 2016 | 606 | 0.280 |
Why?
|
| Poultry | 3 | 2016 | 79 | 0.280 |
Why?
|
| Reproducibility of Results | 36 | 2024 | 20244 | 0.280 |
Why?
|
| Receptors, Androgen | 8 | 2014 | 1091 | 0.280 |
Why?
|
| Antihypertensive Agents | 2 | 2023 | 2026 | 0.270 |
Why?
|
| Nitrosamines | 1 | 2006 | 86 | 0.270 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2014 | 225 | 0.270 |
Why?
|
| Lipoprotein(a) | 8 | 2005 | 490 | 0.270 |
Why?
|
| Neoplasm Metastasis | 11 | 2019 | 4926 | 0.270 |
Why?
|
| Dietary Sucrose | 4 | 2018 | 243 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 3 | 2014 | 126 | 0.270 |
Why?
|
| Methionine | 8 | 2018 | 573 | 0.270 |
Why?
|
| Thrombophlebitis | 8 | 1997 | 289 | 0.260 |
Why?
|
| Publication Bias | 1 | 2007 | 159 | 0.260 |
Why?
|
| Microsatellite Instability | 1 | 2010 | 726 | 0.260 |
Why?
|
| Seasons | 5 | 2012 | 1523 | 0.260 |
Why?
|
| Hyperinsulinism | 2 | 2008 | 402 | 0.260 |
Why?
|
| Superoxide Dismutase | 5 | 2015 | 595 | 0.260 |
Why?
|
| Apolipoproteins A | 2 | 2004 | 96 | 0.260 |
Why?
|
| Prediabetic State | 2 | 2022 | 548 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 7 | 2020 | 2250 | 0.250 |
Why?
|
| Jews | 3 | 2019 | 359 | 0.250 |
Why?
|
| Alcohol Dehydrogenase | 4 | 2015 | 113 | 0.250 |
Why?
|
| Diabetic Angiopathies | 7 | 2007 | 806 | 0.250 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2015 | 1616 | 0.250 |
Why?
|
| Insulin Resistance | 7 | 2015 | 3982 | 0.250 |
Why?
|
| Dementia | 5 | 2025 | 2741 | 0.250 |
Why?
|
| Survival Rate | 25 | 2019 | 12873 | 0.250 |
Why?
|
| Prevalence | 30 | 2022 | 15875 | 0.250 |
Why?
|
| Reference Values | 21 | 2012 | 4941 | 0.250 |
Why?
|
| Caffeine | 14 | 2011 | 703 | 0.240 |
Why?
|
| Double-Blind Method | 37 | 2016 | 12469 | 0.240 |
Why?
|
| Arteriosclerosis | 5 | 2003 | 1056 | 0.240 |
Why?
|
| Adiponectin | 5 | 2024 | 1117 | 0.240 |
Why?
|
| Intra-Abdominal Fat | 4 | 2017 | 624 | 0.240 |
Why?
|
| Physical Exertion | 14 | 2011 | 668 | 0.240 |
Why?
|
| Nutrition Assessment | 16 | 2021 | 740 | 0.240 |
Why?
|
| Magnesium | 12 | 2004 | 816 | 0.240 |
Why?
|
| Sex Hormone-Binding Globulin | 6 | 2012 | 554 | 0.240 |
Why?
|
| Cross-Sectional Studies | 44 | 2022 | 26384 | 0.240 |
Why?
|
| Eating | 12 | 2021 | 1542 | 0.240 |
Why?
|
| Ferritins | 3 | 2021 | 600 | 0.230 |
Why?
|
| Metabolomics | 2 | 2024 | 1675 | 0.230 |
Why?
|
| International Classification of Diseases | 1 | 2010 | 936 | 0.230 |
Why?
|
| Inflammation | 14 | 2024 | 10869 | 0.230 |
Why?
|
| Glycemic Index | 4 | 2011 | 400 | 0.230 |
Why?
|
| Death Certificates | 5 | 2010 | 172 | 0.230 |
Why?
|
| Neovascularization, Pathologic | 5 | 2016 | 2634 | 0.230 |
Why?
|
| Cataract Extraction | 7 | 2001 | 465 | 0.230 |
Why?
|
| Genetic Loci | 4 | 2014 | 2630 | 0.230 |
Why?
|
| Nutritional Support | 1 | 2006 | 178 | 0.230 |
Why?
|
| Factor V | 4 | 1997 | 168 | 0.230 |
Why?
|
| Mass Screening | 5 | 2021 | 5455 | 0.230 |
Why?
|
| Iron | 5 | 2003 | 1813 | 0.230 |
Why?
|
| Genetics, Medical | 1 | 2007 | 334 | 0.230 |
Why?
|
| Skin Neoplasms | 15 | 2020 | 5864 | 0.230 |
Why?
|
| Epidemiologic Methods | 18 | 2019 | 1328 | 0.220 |
Why?
|
| Age Distribution | 19 | 2010 | 2875 | 0.220 |
Why?
|
| Serine Endopeptidases | 4 | 2015 | 1027 | 0.220 |
Why?
|
| Germ-Line Mutation | 6 | 2020 | 1887 | 0.220 |
Why?
|
| Data Interpretation, Statistical | 4 | 2011 | 2714 | 0.220 |
Why?
|
| Nutritional Status | 7 | 2021 | 1627 | 0.220 |
Why?
|
| Maternal Age | 9 | 2000 | 804 | 0.220 |
Why?
|
| Cotinine | 3 | 2018 | 206 | 0.220 |
Why?
|
| Health Status | 11 | 2018 | 4095 | 0.220 |
Why?
|
| Patient Compliance | 9 | 2016 | 2701 | 0.210 |
Why?
|
| Carcinogens | 6 | 2006 | 453 | 0.210 |
Why?
|
| Hematinics | 1 | 2006 | 282 | 0.210 |
Why?
|
| Cataract | 7 | 2001 | 837 | 0.210 |
Why?
|
| Fertilizers | 1 | 2022 | 24 | 0.210 |
Why?
|
| Work Schedule Tolerance | 3 | 2016 | 553 | 0.210 |
Why?
|
| Food Contamination | 2 | 2017 | 193 | 0.210 |
Why?
|
| Hearing Loss | 3 | 2015 | 786 | 0.210 |
Why?
|
| Food Handling | 3 | 2020 | 158 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2020 | 4064 | 0.210 |
Why?
|
| Angina Pectoris | 9 | 2004 | 957 | 0.210 |
Why?
|
| Kidney | 8 | 2017 | 7057 | 0.210 |
Why?
|
| Dyslipidemias | 3 | 2017 | 873 | 0.210 |
Why?
|
| Estrogen Receptor beta | 3 | 2008 | 171 | 0.210 |
Why?
|
| Carotid Artery, Common | 1 | 2003 | 175 | 0.210 |
Why?
|
| Respiratory Tract Diseases | 3 | 2021 | 744 | 0.210 |
Why?
|
| Sleep | 7 | 2022 | 4820 | 0.200 |
Why?
|
| Longitudinal Studies | 25 | 2021 | 14795 | 0.200 |
Why?
|
| Overweight | 5 | 2021 | 2445 | 0.200 |
Why?
|
| Digestive System Neoplasms | 2 | 2021 | 82 | 0.200 |
Why?
|
| Hypoglycemic Agents | 2 | 2023 | 3110 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2009 | 453 | 0.200 |
Why?
|
| Blood Donors | 2 | 2004 | 344 | 0.200 |
Why?
|
| Brain Ischemia | 12 | 2012 | 3008 | 0.200 |
Why?
|
| Smad4 Protein | 2 | 2015 | 193 | 0.200 |
Why?
|
| Vitamin D-Binding Protein | 3 | 2018 | 130 | 0.200 |
Why?
|
| Sex Factors | 24 | 2018 | 10641 | 0.200 |
Why?
|
| Cognition Disorders | 7 | 2013 | 3985 | 0.200 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 400 | 0.200 |
Why?
|
| Cystitis, Interstitial | 2 | 2000 | 68 | 0.200 |
Why?
|
| Hydroxycholecalciferols | 2 | 2006 | 44 | 0.200 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 489 | 0.200 |
Why?
|
| Flavonoids | 3 | 2021 | 447 | 0.200 |
Why?
|
| Conflict of Interest | 1 | 2007 | 555 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 1094 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 6 | 2013 | 2228 | 0.190 |
Why?
|
| Models, Statistical | 6 | 2021 | 5107 | 0.190 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2017 | 156 | 0.190 |
Why?
|
| Data Collection | 9 | 2020 | 3322 | 0.190 |
Why?
|
| Telomerase | 3 | 2016 | 753 | 0.190 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2021 | 60 | 0.190 |
Why?
|
| Receptors, Somatostatin | 2 | 2014 | 138 | 0.190 |
Why?
|
| Glutathione Transferase | 5 | 2002 | 564 | 0.190 |
Why?
|
| Heart Diseases | 9 | 2013 | 2819 | 0.190 |
Why?
|
| Receptors, Calcitriol | 4 | 2012 | 361 | 0.190 |
Why?
|
| Chromosome Mapping | 4 | 2022 | 4624 | 0.190 |
Why?
|
| Apolipoproteins B | 6 | 2005 | 386 | 0.190 |
Why?
|
| Carcinoma, Basal Cell | 5 | 2020 | 565 | 0.180 |
Why?
|
| Carrier Proteins | 6 | 2014 | 4940 | 0.180 |
Why?
|
| Selection Bias | 5 | 2010 | 360 | 0.180 |
Why?
|
| Hypertriglyceridemia | 2 | 2015 | 293 | 0.180 |
Why?
|
| Social Class | 4 | 2017 | 2009 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 10 | 2018 | 9442 | 0.180 |
Why?
|
| Research Design | 16 | 2018 | 6213 | 0.180 |
Why?
|
| Nutritional Sciences | 2 | 2018 | 148 | 0.180 |
Why?
|
| Melatonin | 3 | 2016 | 670 | 0.180 |
Why?
|
| Feces | 2 | 2024 | 1511 | 0.180 |
Why?
|
| Ovary | 4 | 2021 | 965 | 0.180 |
Why?
|
| Prostatic Secretory Proteins | 2 | 2010 | 24 | 0.170 |
Why?
|
| Linkage Disequilibrium | 9 | 2022 | 1998 | 0.170 |
Why?
|
| Fish Oils | 7 | 2013 | 483 | 0.170 |
Why?
|
| Predictive Value of Tests | 23 | 2017 | 15471 | 0.170 |
Why?
|
| Carcinoma, Small Cell | 2 | 2019 | 419 | 0.170 |
Why?
|
| Vitamin D Deficiency | 2 | 2006 | 1388 | 0.170 |
Why?
|
| Micronutrients | 4 | 2021 | 390 | 0.170 |
Why?
|
| Membrane Proteins | 5 | 2017 | 7885 | 0.170 |
Why?
|
| Socioeconomic Factors | 12 | 2019 | 7860 | 0.170 |
Why?
|
| Diet Therapy | 1 | 2021 | 150 | 0.170 |
Why?
|
| Endoribonucleases | 2 | 2013 | 231 | 0.170 |
Why?
|
| Urine | 1 | 2001 | 362 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 3 | 2010 | 208 | 0.170 |
Why?
|
| Calcium Channel Blockers | 3 | 1998 | 691 | 0.170 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 2339 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2023 | 1756 | 0.160 |
Why?
|
| RNA, Neoplasm | 4 | 2015 | 751 | 0.160 |
Why?
|
| Rural Population | 6 | 2021 | 2322 | 0.160 |
Why?
|
| Asia | 4 | 2020 | 629 | 0.160 |
Why?
|
| Iceland | 6 | 2015 | 183 | 0.160 |
Why?
|
| Diabetes Complications | 10 | 2010 | 1320 | 0.160 |
Why?
|
| Isoflavones | 1 | 2000 | 139 | 0.160 |
Why?
|
| Apolipoproteins | 4 | 2004 | 328 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2010 | 277 | 0.160 |
Why?
|
| Myocardial Ischemia | 8 | 2010 | 2139 | 0.160 |
Why?
|
| Trinucleotide Repeats | 6 | 2014 | 257 | 0.160 |
Why?
|
| Fish Proteins | 1 | 2019 | 48 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 414 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 11 | 2021 | 3814 | 0.160 |
Why?
|
| Analgesics | 2 | 2003 | 1072 | 0.160 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 1999 | 577 | 0.160 |
Why?
|
| Evidence-Based Medicine | 6 | 2016 | 3709 | 0.160 |
Why?
|
| Food Preferences | 4 | 2016 | 398 | 0.160 |
Why?
|
| Mental Recall | 8 | 2021 | 1226 | 0.160 |
Why?
|
| Fibrinogen | 4 | 2005 | 892 | 0.160 |
Why?
|
| Breast | 10 | 2000 | 1976 | 0.160 |
Why?
|
| Heme | 3 | 2004 | 316 | 0.160 |
Why?
|
| Lactation | 2 | 1999 | 392 | 0.160 |
Why?
|
| Smoking Cessation | 7 | 2011 | 2084 | 0.160 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2011 | 119 | 0.150 |
Why?
|
| Genetic Pleiotropy | 1 | 2019 | 181 | 0.150 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1998 | 108 | 0.150 |
Why?
|
| Cholesterol, LDL | 10 | 2015 | 2402 | 0.150 |
Why?
|
| Carcinoma, Large Cell | 1 | 2019 | 114 | 0.150 |
Why?
|
| Comorbidity | 20 | 2020 | 10591 | 0.150 |
Why?
|
| Fasting | 11 | 2021 | 1610 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1064 | 0.150 |
Why?
|
| Carbon Dioxide | 1 | 2022 | 1149 | 0.150 |
Why?
|
| Melanoma | 13 | 2015 | 5709 | 0.150 |
Why?
|
| Behavior | 2 | 2017 | 543 | 0.150 |
Why?
|
| Energy Metabolism | 8 | 2017 | 2905 | 0.150 |
Why?
|
| Causality | 6 | 2022 | 1255 | 0.150 |
Why?
|
| Young Adult | 25 | 2022 | 60110 | 0.150 |
Why?
|
| Nicotine | 2 | 2016 | 681 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2021 | 1658 | 0.150 |
Why?
|
| Cysteine | 2 | 2010 | 897 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2009 | 1169 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 359 | 0.140 |
Why?
|
| Research | 1 | 2006 | 1981 | 0.140 |
Why?
|
| Pregnancy, High-Risk | 1 | 1997 | 121 | 0.140 |
Why?
|
| Neoplasms, Second Primary | 2 | 2017 | 1060 | 0.140 |
Why?
|
| Medical History Taking | 4 | 2019 | 779 | 0.140 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 210 | 0.140 |
Why?
|
| Lumbar Vertebrae | 1 | 2006 | 1889 | 0.140 |
Why?
|
| DNA, Neoplasm | 5 | 2009 | 1748 | 0.140 |
Why?
|
| Aptamers, Nucleotide | 1 | 2018 | 163 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 3 | 2016 | 190 | 0.140 |
Why?
|
| Guidelines as Topic | 3 | 2013 | 1398 | 0.140 |
Why?
|
| Dihydrotestosterone | 5 | 1997 | 195 | 0.140 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2009 | 410 | 0.140 |
Why?
|
| Pineal Gland | 2 | 2016 | 158 | 0.140 |
Why?
|
| Functional Food | 1 | 2016 | 19 | 0.130 |
Why?
|
| BRCA1 Protein | 2 | 2016 | 1156 | 0.130 |
Why?
|
| Pyridoxal Phosphate | 3 | 2009 | 123 | 0.130 |
Why?
|
| Immunohistochemistry | 11 | 2015 | 11119 | 0.130 |
Why?
|
| Genetic Association Studies | 7 | 2016 | 2747 | 0.130 |
Why?
|
| Peripheral Vascular Diseases | 4 | 2004 | 489 | 0.130 |
Why?
|
| Alzheimer Disease | 4 | 2009 | 8758 | 0.130 |
Why?
|
| Kynurenine | 1 | 2017 | 142 | 0.130 |
Why?
|
| Calcium | 7 | 2010 | 5792 | 0.130 |
Why?
|
| Telomere | 2 | 2013 | 943 | 0.130 |
Why?
|
| Wisconsin | 7 | 2009 | 122 | 0.130 |
Why?
|
| Carcinoma | 5 | 2011 | 2340 | 0.130 |
Why?
|
| Receptors, Leptin | 2 | 2016 | 352 | 0.130 |
Why?
|
| Dehydroepiandrosterone | 2 | 1994 | 259 | 0.130 |
Why?
|
| Water | 1 | 2022 | 1421 | 0.130 |
Why?
|
| Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
| Fish Products | 2 | 2013 | 31 | 0.130 |
Why?
|
| Glycoproteins | 3 | 2010 | 2202 | 0.130 |
Why?
|
| Coronary Thrombosis | 1 | 1999 | 440 | 0.130 |
Why?
|
| Seeds | 1 | 2016 | 124 | 0.130 |
Why?
|
| Osteopontin | 2 | 2015 | 311 | 0.130 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2016 | 40 | 0.130 |
Why?
|
| Bread | 2 | 2012 | 23 | 0.130 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 346 | 0.130 |
Why?
|
| Sucrose | 1 | 1996 | 158 | 0.130 |
Why?
|
| Methylmercury Compounds | 1 | 2017 | 103 | 0.130 |
Why?
|
| Cyclin D1 | 2 | 2015 | 453 | 0.130 |
Why?
|
| Food Supply | 2 | 2021 | 544 | 0.130 |
Why?
|
| Fractures, Bone | 6 | 2001 | 2063 | 0.130 |
Why?
|
| Sweetening Agents | 1 | 2018 | 290 | 0.130 |
Why?
|
| Premenopause | 5 | 2006 | 1039 | 0.130 |
Why?
|
| Drug Administration Schedule | 7 | 2017 | 4862 | 0.130 |
Why?
|
| Food Analysis | 6 | 2021 | 103 | 0.130 |
Why?
|
| RNA, Messenger | 6 | 2015 | 12809 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 3 | 2009 | 581 | 0.130 |
Why?
|
| Sensitivity and Specificity | 13 | 2019 | 14751 | 0.120 |
Why?
|
| Hemoglobins | 1 | 2021 | 1531 | 0.120 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2014 | 113 | 0.120 |
Why?
|
| Probability | 7 | 2009 | 2483 | 0.120 |
Why?
|
| Macular Degeneration | 3 | 2001 | 1016 | 0.120 |
Why?
|
| Coronary Artery Disease | 6 | 2016 | 6569 | 0.120 |
Why?
|
| Drug Evaluation | 1 | 1996 | 642 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 11 | 2010 | 6085 | 0.120 |
Why?
|
| Epidemiology | 2 | 2008 | 278 | 0.120 |
Why?
|
| Tissue Array Analysis | 5 | 2015 | 551 | 0.120 |
Why?
|
| Parkinson Disease | 1 | 2009 | 2896 | 0.120 |
Why?
|
| Breast Feeding | 5 | 2008 | 1364 | 0.120 |
Why?
|
| Postprandial Period | 3 | 2017 | 320 | 0.120 |
Why?
|
| Oxalates | 3 | 2001 | 99 | 0.120 |
Why?
|
| Body Composition | 7 | 2016 | 2461 | 0.120 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2007 | 99 | 0.120 |
Why?
|
| Genetic Markers | 6 | 2011 | 2604 | 0.120 |
Why?
|
| Quality of Life | 7 | 2017 | 13510 | 0.120 |
Why?
|
| Meningioma | 1 | 2003 | 1226 | 0.120 |
Why?
|
| Social Conformity | 1 | 1994 | 39 | 0.120 |
Why?
|
| Biometry | 2 | 2016 | 570 | 0.120 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2015 | 104 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2015 | 2858 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2003 | 1258 | 0.120 |
Why?
|
| Rectal Neoplasms | 6 | 2017 | 1183 | 0.120 |
Why?
|
| Tunica Intima | 3 | 2010 | 459 | 0.120 |
Why?
|
| Israel | 5 | 2017 | 726 | 0.110 |
Why?
|
| Premature Birth | 3 | 2013 | 1814 | 0.110 |
Why?
|
| Treatment Outcome | 21 | 2018 | 65485 | 0.110 |
Why?
|
| Tissue Plasminogen Activator | 6 | 1997 | 1165 | 0.110 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 1895 | 0.110 |
Why?
|
| Potassium, Dietary | 5 | 2004 | 103 | 0.110 |
Why?
|
| Lipoproteins, LDL | 2 | 1996 | 643 | 0.110 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 306 | 0.110 |
Why?
|
| Thromboembolism | 3 | 1997 | 1004 | 0.110 |
Why?
|
| Tissue Fixation | 1 | 2015 | 245 | 0.110 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 365 | 0.110 |
Why?
|
| Thermogenesis | 2 | 2016 | 494 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2018 | 1157 | 0.110 |
Why?
|
| Adolescent | 38 | 2024 | 89247 | 0.110 |
Why?
|
| Glucose | 3 | 2014 | 4352 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 6 | 2015 | 3629 | 0.110 |
Why?
|
| Isoenzymes | 5 | 2002 | 1687 | 0.110 |
Why?
|
| Leukocytes | 4 | 2016 | 2034 | 0.110 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 3 | 2005 | 78 | 0.110 |
Why?
|
| Formaldehyde | 1 | 2015 | 361 | 0.110 |
Why?
|
| Toes | 11 | 2016 | 209 | 0.110 |
Why?
|
| Analysis of Variance | 11 | 2011 | 6242 | 0.110 |
Why?
|
| Carbon | 1 | 2017 | 672 | 0.110 |
Why?
|
| Occupational Health | 2 | 2016 | 812 | 0.110 |
Why?
|
| Suicide | 5 | 2010 | 1606 | 0.110 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 4363 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2000 | 2269 | 0.110 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2014 | 112 | 0.110 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1992 | 62 | 0.110 |
Why?
|
| Periodontal Diseases | 1 | 2016 | 455 | 0.110 |
Why?
|
| Selenoprotein P | 1 | 2012 | 33 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 202 | 0.100 |
Why?
|
| Hypersensitivity | 2 | 2013 | 1173 | 0.100 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 329 | 0.100 |
Why?
|
| Iron, Dietary | 2 | 2004 | 148 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 387 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 3 | 2016 | 914 | 0.100 |
Why?
|
| Pericardium | 1 | 2017 | 679 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2018 | 562 | 0.100 |
Why?
|
| Religion | 1 | 2016 | 376 | 0.100 |
Why?
|
| Nutritional Requirements | 2 | 2010 | 279 | 0.100 |
Why?
|
| Bile Duct Neoplasms | 1 | 2018 | 615 | 0.100 |
Why?
|
| Fast Foods | 2 | 2016 | 220 | 0.100 |
Why?
|
| Animals | 40 | 2024 | 169408 | 0.100 |
Why?
|
| Water Pollutants, Chemical | 1 | 2017 | 359 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2002 | 2431 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 93 | 0.100 |
Why?
|
| Linoleic Acid | 5 | 2008 | 158 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1994 | 425 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3116 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2014 | 168 | 0.100 |
Why?
|
| Chromosomal Instability | 1 | 2013 | 176 | 0.100 |
Why?
|
| Keratinocytes | 1 | 2017 | 876 | 0.100 |
Why?
|
| Specimen Handling | 2 | 1989 | 708 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2884 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3239 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 4 | 1998 | 399 | 0.100 |
Why?
|
| Reproduction | 4 | 2007 | 646 | 0.100 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 18 | 0.100 |
Why?
|
| Vasculitis | 1 | 2016 | 525 | 0.100 |
Why?
|
| Mannose-Binding Lectin | 1 | 2013 | 146 | 0.100 |
Why?
|
| Quantitative Trait Loci | 4 | 2017 | 2133 | 0.100 |
Why?
|
| Benzothiadiazines | 2 | 2005 | 31 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 2017 | 535 | 0.100 |
Why?
|
| Anemia | 1 | 2021 | 1516 | 0.100 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 268 | 0.100 |
Why?
|
| Asthma | 6 | 2015 | 6293 | 0.100 |
Why?
|
| Recurrence | 9 | 2006 | 8512 | 0.100 |
Why?
|
| Pulmonary Embolism | 7 | 1997 | 2598 | 0.100 |
Why?
|
| Menstrual Cycle | 3 | 2002 | 546 | 0.100 |
Why?
|
| Australia | 4 | 2018 | 1265 | 0.100 |
Why?
|
| Potassium | 5 | 2010 | 1319 | 0.100 |
Why?
|
| DNA Adducts | 2 | 2002 | 95 | 0.100 |
Why?
|
| Lipogenesis | 1 | 2013 | 216 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2001 | 1386 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2009 | 2171 | 0.100 |
Why?
|
| Statistics, Nonparametric | 7 | 2021 | 2862 | 0.090 |
Why?
|
| DNA Methylation | 3 | 2023 | 4432 | 0.090 |
Why?
|
| Receptors, Adiponectin | 1 | 2011 | 82 | 0.090 |
Why?
|
| Sample Size | 2 | 2022 | 848 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2016 | 6546 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2013 | 794 | 0.090 |
Why?
|
| Acrylamide | 1 | 2011 | 59 | 0.090 |
Why?
|
| Cyclobutanes | 1 | 2011 | 57 | 0.090 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 91 | 0.090 |
Why?
|
| Aspartate Aminotransferases | 2 | 2016 | 414 | 0.090 |
Why?
|
| Massachusetts | 15 | 2009 | 8888 | 0.090 |
Why?
|
| Hypercholesterolemia | 11 | 2009 | 1145 | 0.090 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2012 | 320 | 0.090 |
Why?
|
| Estradiol | 7 | 2008 | 1952 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 384 | 0.090 |
Why?
|
| Glycine | 1 | 2014 | 672 | 0.090 |
Why?
|
| Autopsy | 1 | 2015 | 1013 | 0.090 |
Why?
|
| Carbohydrates | 1 | 2013 | 389 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2015 | 2960 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 16 | 2010 | 10778 | 0.090 |
Why?
|
| Chromosomes, Human, Y | 1 | 2012 | 164 | 0.090 |
Why?
|
| Zinc | 4 | 2004 | 678 | 0.090 |
Why?
|
| Erythrocytes | 4 | 2007 | 2421 | 0.090 |
Why?
|
| Sweden | 6 | 2017 | 1382 | 0.090 |
Why?
|
| Epithelial Cells | 5 | 2017 | 3701 | 0.090 |
Why?
|
| Racemases and Epimerases | 1 | 2011 | 114 | 0.090 |
Why?
|
| Creatinine | 7 | 2016 | 1917 | 0.090 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 2001 | 28 | 0.090 |
Why?
|
| Linear Models | 9 | 2014 | 5890 | 0.090 |
Why?
|
| Hip Fractures | 6 | 1999 | 996 | 0.090 |
Why?
|
| Choline | 1 | 2012 | 522 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 62 | 0.090 |
Why?
|
| Heterozygote | 4 | 2009 | 2798 | 0.090 |
Why?
|
| Colonic Polyps | 5 | 1997 | 557 | 0.090 |
Why?
|
| Parents | 2 | 2014 | 3597 | 0.090 |
Why?
|
| Legislation, Food | 1 | 2010 | 17 | 0.090 |
Why?
|
| Transportation | 2 | 1989 | 217 | 0.090 |
Why?
|
| Digoxin | 1 | 2011 | 246 | 0.090 |
Why?
|
| Alanine Transaminase | 2 | 2016 | 606 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1994 | 746 | 0.090 |
Why?
|
| Boston | 10 | 2017 | 9375 | 0.090 |
Why?
|
| Dinucleotide Repeats | 2 | 2007 | 28 | 0.090 |
Why?
|
| Phosphorus | 1 | 2011 | 336 | 0.080 |
Why?
|
| Genes, myc | 2 | 2009 | 391 | 0.080 |
Why?
|
| Pregnancy | 15 | 2023 | 30175 | 0.080 |
Why?
|
| Waist-Hip Ratio | 3 | 2006 | 520 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 309 | 0.080 |
Why?
|
| Disease-Free Survival | 5 | 2014 | 6856 | 0.080 |
Why?
|
| Prolactin | 3 | 1996 | 627 | 0.080 |
Why?
|
| Trichomonas Infections | 1 | 2009 | 41 | 0.080 |
Why?
|
| Betaine | 2 | 2024 | 90 | 0.080 |
Why?
|
| Haplotypes | 5 | 2022 | 2725 | 0.080 |
Why?
|
| Gene Fusion | 1 | 2012 | 357 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 1999 | 2080 | 0.080 |
Why?
|
| Muscle Strength | 1 | 2014 | 641 | 0.080 |
Why?
|
| Drinking | 2 | 2002 | 196 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1962 | 0.080 |
Why?
|
| Arm | 3 | 2021 | 590 | 0.080 |
Why?
|
| Aromatase | 1 | 2009 | 147 | 0.080 |
Why?
|
| Hormones | 4 | 2006 | 871 | 0.080 |
Why?
|
| Trichomonas vaginalis | 1 | 2009 | 70 | 0.080 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2848 | 0.080 |
Why?
|
| Lactones | 1 | 2011 | 316 | 0.080 |
Why?
|
| Endostatins | 1 | 2009 | 168 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2017 | 36861 | 0.080 |
Why?
|
| Molecular Epidemiology | 3 | 2019 | 473 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2016 | 2025 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2460 | 0.080 |
Why?
|
| Blood Preservation | 1 | 1989 | 169 | 0.080 |
Why?
|
| Precancerous Conditions | 3 | 2010 | 985 | 0.080 |
Why?
|
| Public Policy | 1 | 1993 | 552 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2013 | 1535 | 0.080 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2011 | 348 | 0.080 |
Why?
|
| Residence Characteristics | 4 | 2013 | 2122 | 0.080 |
Why?
|
| Coronary Artery Bypass | 2 | 1997 | 2194 | 0.080 |
Why?
|
| Health Maintenance Organizations | 1 | 2011 | 657 | 0.080 |
Why?
|
| Walking | 5 | 2020 | 1201 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 6 | 2007 | 2763 | 0.080 |
Why?
|
| Oleic Acid | 2 | 2008 | 91 | 0.080 |
Why?
|
| Homeostasis | 1 | 1999 | 3348 | 0.080 |
Why?
|
| Flavonols | 2 | 2007 | 85 | 0.080 |
Why?
|
| Lipoproteins, HDL | 4 | 2007 | 682 | 0.080 |
Why?
|
| Selenoproteins | 1 | 2010 | 216 | 0.080 |
Why?
|
| Penetrance | 2 | 2011 | 386 | 0.080 |
Why?
|
| Antibodies, Protozoan | 1 | 2009 | 251 | 0.080 |
Why?
|
| Sex Distribution | 6 | 2007 | 2280 | 0.080 |
Why?
|
| Plant Proteins | 1 | 2010 | 376 | 0.080 |
Why?
|
| Tunica Media | 2 | 2010 | 111 | 0.080 |
Why?
|
| Bone Neoplasms | 4 | 2015 | 2565 | 0.080 |
Why?
|
| Forearm Injuries | 3 | 1996 | 68 | 0.070 |
Why?
|
| Platelet Aggregation | 4 | 1988 | 769 | 0.070 |
Why?
|
| Brassica | 2 | 2007 | 39 | 0.070 |
Why?
|
| Mutation | 6 | 2016 | 30266 | 0.070 |
Why?
|
| Anti-Obesity Agents | 1 | 2011 | 240 | 0.070 |
Why?
|
| Stress, Psychological | 3 | 2010 | 4542 | 0.070 |
Why?
|
| Reproductive History | 3 | 2003 | 210 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2015 | 23652 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2016 | 2507 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2009 | 419 | 0.070 |
Why?
|
| Thromboxane A2 | 2 | 1986 | 87 | 0.070 |
Why?
|
| China | 7 | 2013 | 2395 | 0.070 |
Why?
|
| Arachidonic Acids | 1 | 1988 | 296 | 0.070 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 1890 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 587 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2019 | 1886 | 0.070 |
Why?
|
| Carbonated Beverages | 2 | 2005 | 210 | 0.070 |
Why?
|
| Fear | 1 | 2016 | 1494 | 0.070 |
Why?
|
| Watchful Waiting | 1 | 2011 | 498 | 0.070 |
Why?
|
| Benchmarking | 1 | 2014 | 1058 | 0.070 |
Why?
|
| Testosterone | 6 | 1998 | 2494 | 0.070 |
Why?
|
| ROC Curve | 3 | 2018 | 3629 | 0.070 |
Why?
|
| Flavones | 1 | 2007 | 66 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 599 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2336 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2000 | 7148 | 0.070 |
Why?
|
| Duodenal Ulcer | 2 | 1997 | 117 | 0.070 |
Why?
|
| Oncogenes | 3 | 2009 | 1236 | 0.070 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 7609 | 0.070 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 937 | 0.070 |
Why?
|
| Epoprostenol | 1 | 1988 | 246 | 0.070 |
Why?
|
| Spouses | 1 | 2009 | 286 | 0.070 |
Why?
|
| Immunoglobulin E | 2 | 2011 | 1506 | 0.070 |
Why?
|
| SEER Program | 3 | 2019 | 1473 | 0.070 |
Why?
|
| Citric Acid | 2 | 2010 | 124 | 0.070 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2015 | 930 | 0.070 |
Why?
|
| Organizations, Nonprofit | 1 | 2007 | 105 | 0.070 |
Why?
|
| Lymphoma | 2 | 1999 | 1900 | 0.070 |
Why?
|
| Hyperglycemia | 2 | 2013 | 1389 | 0.070 |
Why?
|
| Streptokinase | 2 | 1985 | 186 | 0.070 |
Why?
|
| Hyperhomocysteinemia | 1 | 2007 | 118 | 0.070 |
Why?
|
| Multiple Myeloma | 2 | 2014 | 5195 | 0.070 |
Why?
|
| Renal Insufficiency | 2 | 2003 | 812 | 0.070 |
Why?
|
| Motivation | 1 | 2016 | 2030 | 0.070 |
Why?
|
| Genes, BRCA1 | 1 | 2010 | 756 | 0.070 |
Why?
|
| Radioimmunoassay | 4 | 2001 | 862 | 0.070 |
Why?
|
| Leukemia | 1 | 1994 | 1520 | 0.070 |
Why?
|
| Proline | 2 | 2024 | 455 | 0.070 |
Why?
|
| Epidemiologic Research Design | 2 | 2013 | 368 | 0.070 |
Why?
|
| National Cancer Institute (U.S.) | 3 | 2013 | 300 | 0.070 |
Why?
|
| DNA Damage | 3 | 2016 | 2472 | 0.070 |
Why?
|
| Population Surveillance | 6 | 2010 | 2597 | 0.060 |
Why?
|
| Retrospective Studies | 15 | 2021 | 81892 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 899 | 0.060 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 58 | 0.060 |
Why?
|
| Software | 1 | 2020 | 4480 | 0.060 |
Why?
|
| Blood Platelets | 5 | 2001 | 2479 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2004 | 588 | 0.060 |
Why?
|
| Solanum tuberosum | 1 | 2006 | 47 | 0.060 |
Why?
|
| Registries | 9 | 2014 | 8384 | 0.060 |
Why?
|
| Cardiology | 1 | 1997 | 1701 | 0.060 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 582 | 0.060 |
Why?
|
| Random Allocation | 11 | 2002 | 2396 | 0.060 |
Why?
|
| Apolipoprotein C-III | 2 | 2004 | 210 | 0.060 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 1999 | 325 | 0.060 |
Why?
|
| Placebos | 7 | 2007 | 1668 | 0.060 |
Why?
|
| Finland | 2 | 2003 | 609 | 0.060 |
Why?
|
| Calorimetry, Indirect | 2 | 2016 | 176 | 0.060 |
Why?
|
| Glutathione Peroxidase | 3 | 2014 | 259 | 0.060 |
Why?
|
| Sunburn | 5 | 1999 | 156 | 0.060 |
Why?
|
| Spain | 2 | 2017 | 485 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1997 | 781 | 0.060 |
Why?
|
| Sodium, Dietary | 4 | 1998 | 426 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2017 | 3811 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2003 | 5801 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 1 | 2011 | 873 | 0.060 |
Why?
|
| Lymphatic Metastasis | 5 | 2014 | 2916 | 0.060 |
Why?
|
| Malnutrition | 2 | 2021 | 631 | 0.060 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 2007 | 271 | 0.060 |
Why?
|
| Homozygote | 3 | 2001 | 1779 | 0.060 |
Why?
|
| Vitamin K 1 | 1 | 2005 | 47 | 0.060 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 1999 | 517 | 0.060 |
Why?
|
| Pre-Eclampsia | 3 | 1999 | 1251 | 0.060 |
Why?
|
| Nephrocalcinosis | 1 | 2005 | 51 | 0.060 |
Why?
|
| Fertility | 2 | 2021 | 770 | 0.060 |
Why?
|
| Iron Overload | 2 | 2004 | 246 | 0.060 |
Why?
|
| Menopause, Premature | 2 | 2021 | 124 | 0.060 |
Why?
|
| Carotid Arteries | 2 | 2010 | 943 | 0.060 |
Why?
|
| Nuclear Family | 2 | 2014 | 311 | 0.060 |
Why?
|
| Databases, Factual | 3 | 2018 | 8095 | 0.060 |
Why?
|
| Phytic Acid | 1 | 2004 | 22 | 0.060 |
Why?
|
| Greece | 2 | 2003 | 340 | 0.060 |
Why?
|
| Tobacco, Smokeless | 1 | 2005 | 133 | 0.060 |
Why?
|
| Parathyroid Hormone | 1 | 2011 | 1803 | 0.060 |
Why?
|
| Central Nervous System Depressants | 2 | 2005 | 164 | 0.060 |
Why?
|
| Proteomics | 1 | 2018 | 3913 | 0.060 |
Why?
|
| Sex Characteristics | 6 | 2016 | 2660 | 0.060 |
Why?
|
| India | 4 | 2021 | 2325 | 0.060 |
Why?
|
| Cholecystitis | 1 | 2005 | 181 | 0.060 |
Why?
|
| Ejaculation | 1 | 2004 | 59 | 0.060 |
Why?
|
| Liver | 2 | 2017 | 7579 | 0.060 |
Why?
|
| Hysterectomy | 6 | 1998 | 866 | 0.060 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 1106 | 0.060 |
Why?
|
| Biological Availability | 3 | 2018 | 392 | 0.060 |
Why?
|
| Margarine | 2 | 1994 | 17 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2011 | 12174 | 0.060 |
Why?
|
| Endothelium, Vascular | 3 | 2005 | 4428 | 0.060 |
Why?
|
| Genomic Imprinting | 2 | 2017 | 326 | 0.060 |
Why?
|
| Dental Care | 2 | 1998 | 286 | 0.060 |
Why?
|
| Chromium | 1 | 2004 | 133 | 0.060 |
Why?
|
| Genes, Neoplasm | 1 | 2005 | 371 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 1812 | 0.060 |
Why?
|
| Japan | 2 | 2011 | 1418 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 257 | 0.060 |
Why?
|
| Allergens | 1 | 2011 | 1444 | 0.060 |
Why?
|
| Thymidylate Synthase | 1 | 2003 | 74 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2002 | 828 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2010 | 2592 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2011 | 3200 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2007 | 627 | 0.050 |
Why?
|
| Carotid Artery Diseases | 1 | 2010 | 878 | 0.050 |
Why?
|
| Leiomyoma | 2 | 1998 | 644 | 0.050 |
Why?
|
| Phenotype | 8 | 2022 | 16735 | 0.050 |
Why?
|
| Puberty, Delayed | 1 | 2024 | 124 | 0.050 |
Why?
|
| Depression | 2 | 2016 | 8240 | 0.050 |
Why?
|
| Periodicity | 2 | 2002 | 348 | 0.050 |
Why?
|
| New Hampshire | 4 | 2009 | 174 | 0.050 |
Why?
|
| Butter | 1 | 2003 | 22 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8745 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 1997 | 1539 | 0.050 |
Why?
|
| Automobiles | 1 | 2004 | 103 | 0.050 |
Why?
|
| Temperature | 2 | 1989 | 2235 | 0.050 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 381 | 0.050 |
Why?
|
| Kidney Neoplasms | 3 | 2020 | 4300 | 0.050 |
Why?
|
| Nucleosides | 1 | 2023 | 131 | 0.050 |
Why?
|
| United States Department of Agriculture | 1 | 2003 | 47 | 0.050 |
Why?
|
| Drug Combinations | 2 | 2002 | 2088 | 0.050 |
Why?
|
| Epithelium | 6 | 2017 | 1607 | 0.050 |
Why?
|
| Arginine | 1 | 2006 | 932 | 0.050 |
Why?
|
| Puberty, Precocious | 1 | 2024 | 166 | 0.050 |
Why?
|
| Steroid Hydroxylases | 2 | 2013 | 93 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 696 | 0.050 |
Why?
|
| Pravastatin | 2 | 2001 | 393 | 0.050 |
Why?
|
| Point Mutation | 3 | 1997 | 1595 | 0.050 |
Why?
|
| Proteins | 2 | 2014 | 6011 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2008 | 1904 | 0.050 |
Why?
|
| Psychological Tests | 1 | 2005 | 642 | 0.050 |
Why?
|
| DNA | 6 | 2013 | 7214 | 0.050 |
Why?
|
| Urban Population | 2 | 2021 | 2045 | 0.050 |
Why?
|
| Intention | 1 | 2005 | 348 | 0.050 |
Why?
|
| Gallbladder Diseases | 1 | 2003 | 139 | 0.050 |
Why?
|
| Sigmoidoscopy | 3 | 1998 | 150 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 4784 | 0.050 |
Why?
|
| Defecation | 1 | 2023 | 191 | 0.050 |
Why?
|
| Professional-Patient Relations | 1 | 2007 | 725 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3608 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2014 | 2055 | 0.050 |
Why?
|
| Asbestos | 1 | 2004 | 251 | 0.050 |
Why?
|
| Infertility, Female | 3 | 1998 | 764 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 6 | 2011 | 2660 | 0.050 |
Why?
|
| Leukopenia | 1 | 1982 | 212 | 0.050 |
Why?
|
| Mercury | 2 | 2002 | 289 | 0.050 |
Why?
|
| Gene Expression | 1 | 2014 | 7602 | 0.050 |
Why?
|
| Eicosapentaenoic Acid | 3 | 2014 | 565 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 2541 | 0.050 |
Why?
|
| Bedding and Linens | 1 | 2001 | 41 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5803 | 0.050 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2001 | 88 | 0.050 |
Why?
|
| Calibration | 1 | 2024 | 823 | 0.050 |
Why?
|
| Electrocardiography | 6 | 2001 | 6413 | 0.050 |
Why?
|
| Hyperoxaluria | 1 | 2001 | 33 | 0.050 |
Why?
|
| Diastole | 2 | 2000 | 784 | 0.050 |
Why?
|
| Diabetes, Gestational | 3 | 1997 | 1260 | 0.050 |
Why?
|
| Marital Status | 2 | 2000 | 426 | 0.050 |
Why?
|
| Organ Size | 2 | 2016 | 2268 | 0.050 |
Why?
|
| Infant, Premature | 2 | 2008 | 2121 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4980 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2007 | 789 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 81 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1083 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2022 | 1183 | 0.050 |
Why?
|
| Demography | 3 | 2016 | 1643 | 0.050 |
Why?
|
| Sunlight | 3 | 1991 | 337 | 0.050 |
Why?
|
| Swine | 2 | 2011 | 5998 | 0.050 |
Why?
|
| cdc25 Phosphatases | 1 | 2000 | 60 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2005 | 880 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 115 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 108 | 0.050 |
Why?
|
| Apoptosis | 4 | 2014 | 9528 | 0.040 |
Why?
|
| Cholesterol, VLDL | 1 | 2000 | 70 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 111 | 0.040 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2000 | 88 | 0.040 |
Why?
|
| Hemochromatosis | 1 | 2002 | 176 | 0.040 |
Why?
|
| DNA Primers | 2 | 2009 | 2827 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 3 | 2011 | 157 | 0.040 |
Why?
|
| Cyclin E | 1 | 2000 | 156 | 0.040 |
Why?
|
| Riboflavin | 2 | 1998 | 107 | 0.040 |
Why?
|
| Medical Records | 6 | 2007 | 1411 | 0.040 |
Why?
|
| State Medicine | 2 | 2017 | 219 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2003 | 3780 | 0.040 |
Why?
|
| Cardiovascular System | 2 | 2013 | 840 | 0.040 |
Why?
|
| Phytoestrogens | 1 | 2000 | 59 | 0.040 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2000 | 52 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2001 | 289 | 0.040 |
Why?
|
| Xanthophylls | 4 | 2003 | 95 | 0.040 |
Why?
|
| Circadian Rhythm | 3 | 2016 | 2593 | 0.040 |
Why?
|
| Educational Status | 3 | 2011 | 2515 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2002 | 963 | 0.040 |
Why?
|
| Diuretics | 4 | 2005 | 614 | 0.040 |
Why?
|
| Breast Diseases | 2 | 1993 | 442 | 0.040 |
Why?
|
| Dehydroepiandrosterone Sulfate | 3 | 1997 | 241 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2011 | 2192 | 0.040 |
Why?
|
| Receptors, Collagen | 1 | 1999 | 25 | 0.040 |
Why?
|
| Ethiopia | 1 | 2021 | 483 | 0.040 |
Why?
|
| Plant Preparations | 1 | 2000 | 94 | 0.040 |
Why?
|
| Uterine Neoplasms | 2 | 1998 | 1424 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 785 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 2059 | 0.040 |
Why?
|
| Debrisoquin | 1 | 1998 | 6 | 0.040 |
Why?
|
| Lutein | 4 | 2003 | 123 | 0.040 |
Why?
|
| American Heart Association | 2 | 2001 | 1051 | 0.040 |
Why?
|
| Drug Interactions | 4 | 2005 | 1421 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 80 | 0.040 |
Why?
|
| Chlamydophila pneumoniae | 1 | 1999 | 53 | 0.040 |
Why?
|
| Self Disclosure | 2 | 2002 | 248 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 1133 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 594 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 353 | 0.040 |
Why?
|
| Bone and Bones | 2 | 2021 | 2589 | 0.040 |
Why?
|
| Immunoglobulin G | 3 | 2001 | 4568 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 1999 | 150 | 0.040 |
Why?
|
| Cattle | 3 | 2012 | 3820 | 0.040 |
Why?
|
| Africa South of the Sahara | 1 | 2021 | 752 | 0.040 |
Why?
|
| Drug Utilization | 2 | 2002 | 1191 | 0.040 |
Why?
|
| Administration, Intravaginal | 1 | 2018 | 149 | 0.040 |
Why?
|
| Respiration Disorders | 1 | 2022 | 365 | 0.040 |
Why?
|
| Urinary Retention | 1 | 1999 | 107 | 0.040 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1999 | 350 | 0.040 |
Why?
|
| Systole | 1 | 2000 | 937 | 0.040 |
Why?
|
| Fabaceae | 2 | 2011 | 103 | 0.040 |
Why?
|
| Serine | 1 | 2002 | 831 | 0.040 |
Why?
|
| Leucine | 1 | 1999 | 548 | 0.040 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 1998 | 87 | 0.040 |
Why?
|
| Calcium Oxalate | 1 | 1998 | 75 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2000 | 3724 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 1998 | 100 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2015 | 1645 | 0.040 |
Why?
|
| Valine | 1 | 1999 | 410 | 0.040 |
Why?
|
| Matched-Pair Analysis | 2 | 1995 | 286 | 0.040 |
Why?
|
| Verbal Learning | 1 | 2000 | 465 | 0.040 |
Why?
|
| Keratins | 2 | 1989 | 502 | 0.040 |
Why?
|
| Health | 1 | 2001 | 398 | 0.040 |
Why?
|
| France | 1 | 1999 | 497 | 0.040 |
Why?
|
| Thrombosis | 3 | 2001 | 2956 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2911 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 4 | 2002 | 1002 | 0.040 |
Why?
|
| Helicobacter pylori | 1 | 2001 | 380 | 0.040 |
Why?
|
| Postoperative Complications | 4 | 2014 | 15889 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2012 | 76 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2007 | 3518 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2001 | 390 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2001 | 542 | 0.040 |
Why?
|
| Intestinal Polyps | 1 | 1997 | 105 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2002 | 2674 | 0.040 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1999 | 183 | 0.040 |
Why?
|
| Mesothelioma | 1 | 2004 | 811 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 1207 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2001 | 638 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 661 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2000 | 506 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2010 | 628 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2007 | 767 | 0.040 |
Why?
|
| Telephone | 3 | 2011 | 630 | 0.040 |
Why?
|
| Absorption | 1 | 1997 | 243 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 911 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1716 | 0.040 |
Why?
|
| Estrone | 2 | 1995 | 234 | 0.040 |
Why?
|
| Retinoids | 1 | 1997 | 99 | 0.030 |
Why?
|
| Microarray Analysis | 2 | 2011 | 755 | 0.030 |
Why?
|
| Metabolome | 1 | 2024 | 1009 | 0.030 |
Why?
|
| Oral Hygiene | 1 | 1998 | 132 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 664 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2004 | 2730 | 0.030 |
Why?
|
| Single-Blind Method | 3 | 2007 | 1585 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1541 | 0.030 |
Why?
|
| Androstane-3,17-diol | 1 | 1996 | 20 | 0.030 |
Why?
|
| Food, Preserved | 1 | 2016 | 13 | 0.030 |
Why?
|
| Kidney Function Tests | 2 | 2013 | 684 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
| Food Additives | 1 | 1996 | 23 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 1248 | 0.030 |
Why?
|
| Interviews as Topic | 3 | 2009 | 2742 | 0.030 |
Why?
|
| Body Burden | 1 | 2017 | 158 | 0.030 |
Why?
|
| Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 173 | 0.030 |
Why?
|
| Sports | 1 | 2002 | 703 | 0.030 |
Why?
|
| Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2002 | 1336 | 0.030 |
Why?
|
| Gout | 1 | 2003 | 621 | 0.030 |
Why?
|
| Thromboxane B2 | 4 | 1990 | 143 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1903 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5150 | 0.030 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 1997 | 117 | 0.030 |
Why?
|
| Social Support | 2 | 2016 | 2193 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3836 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1750 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2003 | 848 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2001 | 975 | 0.030 |
Why?
|
| Cholesterol, Dietary | 4 | 2001 | 224 | 0.030 |
Why?
|
| Fructose | 1 | 1998 | 284 | 0.030 |
Why?
|
| Cell Proliferation | 4 | 2014 | 10486 | 0.030 |
Why?
|
| Infant, Newborn | 9 | 2013 | 26394 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 1423 | 0.030 |
Why?
|
| Finasteride | 1 | 1996 | 86 | 0.030 |
Why?
|
| Osmolar Concentration | 3 | 2009 | 657 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 279 | 0.030 |
Why?
|
| Infection Control | 1 | 2003 | 984 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 246 | 0.030 |
Why?
|
| Drinking Behavior | 1 | 1996 | 103 | 0.030 |
Why?
|
| Korea | 1 | 2015 | 97 | 0.030 |
Why?
|
| Chlamydia Infections | 1 | 1999 | 365 | 0.030 |
Why?
|
| Mice | 6 | 2024 | 82074 | 0.030 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 2493 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2016 | 138 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2014 | 2437 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2009 | 3912 | 0.030 |
Why?
|
| Diverticulum, Colon | 1 | 1995 | 32 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1363 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1741 | 0.030 |
Why?
|
| Cholesterol Esters | 1 | 1995 | 72 | 0.030 |
Why?
|
| Base Sequence | 6 | 2012 | 12430 | 0.030 |
Why?
|
| Thigh | 1 | 2016 | 239 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2001 | 684 | 0.030 |
Why?
|
| Tryptophan | 1 | 2017 | 482 | 0.030 |
Why?
|
| Simplexvirus | 1 | 1998 | 805 | 0.030 |
Why?
|
| Uric Acid | 1 | 2001 | 806 | 0.030 |
Why?
|
| Arachidonic Acid | 2 | 2005 | 429 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 749 | 0.030 |
Why?
|
| United States Public Health Service | 1 | 1994 | 31 | 0.030 |
Why?
|
| Plant Oils | 3 | 2005 | 199 | 0.030 |
Why?
|
| Androstenedione | 1 | 1995 | 132 | 0.030 |
Why?
|
| Netherlands | 2 | 2010 | 2277 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2002 | 1281 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 1999 | 1039 | 0.030 |
Why?
|
| Morbidity | 3 | 2011 | 1757 | 0.030 |
Why?
|
| Stearic Acids | 1 | 2014 | 56 | 0.030 |
Why?
|
| Family Health | 2 | 2007 | 1255 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1999 | 967 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2014 | 2941 | 0.030 |
Why?
|
| Bone Density | 2 | 2001 | 3573 | 0.030 |
Why?
|
| Social Security | 1 | 1994 | 101 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 59 | 0.030 |
Why?
|
| Anovulation | 1 | 1994 | 54 | 0.030 |
Why?
|
| Integrins | 1 | 1999 | 843 | 0.030 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2014 | 30 | 0.030 |
Why?
|
| Anticholesteremic Agents | 1 | 2001 | 972 | 0.030 |
Why?
|
| Radius Fractures | 2 | 1997 | 515 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2015 | 204 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 1998 | 753 | 0.030 |
Why?
|
| Pancreas | 1 | 2001 | 1700 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 1994 | 150 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1731 | 0.030 |
Why?
|
| Survival | 2 | 2005 | 160 | 0.030 |
Why?
|
| Statistics as Topic | 3 | 2003 | 2359 | 0.030 |
Why?
|
| Paternal Age | 2 | 1991 | 87 | 0.030 |
Why?
|
| Retinol-Binding Proteins | 2 | 2011 | 67 | 0.030 |
Why?
|
| Polysomnography | 1 | 2021 | 1871 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 215 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 369 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2002 | 984 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
| Occupational Diseases | 1 | 2002 | 1458 | 0.030 |
Why?
|
| Bacteria | 1 | 2024 | 2219 | 0.030 |
Why?
|
| Memory, Short-Term | 1 | 2000 | 1010 | 0.030 |
Why?
|
| Sterilization, Tubal | 1 | 1993 | 78 | 0.030 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2015 | 251 | 0.030 |
Why?
|
| Laboratories | 1 | 2017 | 463 | 0.030 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 1515 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 135 | 0.030 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 403 | 0.030 |
Why?
|
| Adenomatous Polyps | 1 | 1994 | 109 | 0.030 |
Why?
|
| Heart Function Tests | 5 | 1969 | 317 | 0.030 |
Why?
|
| Hair Color | 4 | 1999 | 131 | 0.030 |
Why?
|
| Growth Substances | 2 | 1988 | 760 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 526 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 2252 | 0.030 |
Why?
|
| Tablets, Enteric-Coated | 3 | 1986 | 20 | 0.030 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2012 | 22 | 0.030 |
Why?
|
| Plasminogen Inactivators | 1 | 1992 | 37 | 0.030 |
Why?
|
| Cell Line, Tumor | 4 | 2011 | 17174 | 0.030 |
Why?
|
| Computational Biology | 2 | 2015 | 3562 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 4053 | 0.030 |
Why?
|
| Bleeding Time | 3 | 1986 | 83 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 1390 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1997 | 785 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 57 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2013 | 4148 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2016 | 603 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 497 | 0.020 |
Why?
|
| Sphingomyelins | 1 | 2012 | 105 | 0.020 |
Why?
|
| Dentists | 2 | 2005 | 176 | 0.020 |
Why?
|
| Homocystinuria | 1 | 1992 | 65 | 0.020 |
Why?
|
| Child | 7 | 2024 | 80969 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
| Lanosterol | 1 | 2011 | 2 | 0.020 |
Why?
|
| Estradiol Congeners | 1 | 1991 | 22 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 153 | 0.020 |
Why?
|
| Censuses | 1 | 2013 | 198 | 0.020 |
Why?
|
| Jogging | 1 | 2011 | 18 | 0.020 |
Why?
|
| Stereoisomerism | 3 | 2001 | 612 | 0.020 |
Why?
|
| Women | 1 | 1993 | 225 | 0.020 |
Why?
|
| Survivors | 2 | 2015 | 2383 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 222 | 0.020 |
Why?
|
| Skin Pigmentation | 3 | 2006 | 281 | 0.020 |
Why?
|
| Phytosterols | 1 | 2011 | 55 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2013 | 173 | 0.020 |
Why?
|
| Phobic Disorders | 1 | 1994 | 441 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2000 | 2492 | 0.020 |
Why?
|
| Sunscreening Agents | 1 | 1992 | 139 | 0.020 |
Why?
|
| Spirituality | 1 | 2016 | 430 | 0.020 |
Why?
|
| Developing Countries | 1 | 2004 | 2906 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 1839 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3438 | 0.020 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 1991 | 59 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1998 | 1360 | 0.020 |
Why?
|
| Phospholipids | 1 | 1995 | 787 | 0.020 |
Why?
|
| Poultry Products | 1 | 2010 | 10 | 0.020 |
Why?
|
| Oxalic Acid | 1 | 2010 | 20 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2002 | 8317 | 0.020 |
Why?
|
| Clothing | 1 | 1991 | 96 | 0.020 |
Why?
|
| Physical Fitness | 3 | 2005 | 744 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2012 | 406 | 0.020 |
Why?
|
| Commerce | 1 | 1996 | 613 | 0.020 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2015 | 878 | 0.020 |
Why?
|
| Fibrinolysis | 1 | 1992 | 331 | 0.020 |
Why?
|
| Linoleic Acids | 2 | 1987 | 39 | 0.020 |
Why?
|
| Colorimetry | 1 | 2011 | 151 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2012 | 592 | 0.020 |
Why?
|
| Temperance | 2 | 2001 | 88 | 0.020 |
Why?
|
| Rectum | 2 | 2011 | 900 | 0.020 |
Why?
|
| Swimming | 1 | 2011 | 210 | 0.020 |
Why?
|
| Biomedical Research | 2 | 2018 | 3463 | 0.020 |
Why?
|
| Serpins | 1 | 2011 | 246 | 0.020 |
Why?
|
| Dancing | 1 | 2011 | 105 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 705 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1758 | 0.020 |
Why?
|
| Models, Biological | 2 | 2020 | 9499 | 0.020 |
Why?
|
| Bicycling | 1 | 2011 | 177 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 917 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 643 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 22381 | 0.020 |
Why?
|
| Menstruation | 2 | 1995 | 310 | 0.020 |
Why?
|
| Community Health Planning | 1 | 2010 | 164 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2015 | 911 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 1995 | 999 | 0.020 |
Why?
|
| Sulfates | 1 | 2010 | 379 | 0.020 |
Why?
|
| Androgens | 1 | 1997 | 1285 | 0.020 |
Why?
|
| Urban Health | 2 | 2005 | 535 | 0.020 |
Why?
|
| Genome, Human | 1 | 2022 | 4456 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3588 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 478 | 0.020 |
Why?
|
| Posture | 4 | 1972 | 957 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 805 | 0.020 |
Why?
|
| Albuminuria | 1 | 2013 | 658 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 13020 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 3450 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1737 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2005 | 2258 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 1986 | 318 | 0.020 |
Why?
|
| Epistasis, Genetic | 1 | 2011 | 353 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 310 | 0.020 |
Why?
|
| Solvents | 1 | 1990 | 298 | 0.020 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 1988 | 15 | 0.020 |
Why?
|
| Glioblastoma | 2 | 2015 | 3525 | 0.020 |
Why?
|
| Vimentin | 1 | 1989 | 257 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1988 | 80 | 0.020 |
Why?
|
| Vascular Diseases | 1 | 1997 | 1162 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2009 | 508 | 0.020 |
Why?
|
| Exons | 2 | 2007 | 2395 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 505 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 3214 | 0.020 |
Why?
|
| California | 1 | 2012 | 1443 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 4 | 2000 | 6131 | 0.020 |
Why?
|
| Acne Vulgaris | 1 | 2013 | 352 | 0.020 |
Why?
|
| Wyoming | 3 | 1993 | 13 | 0.020 |
Why?
|
| Cardiac Output | 9 | 1972 | 838 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1997 | 1679 | 0.020 |
Why?
|
| Blood Circulation | 1 | 1969 | 248 | 0.020 |
Why?
|
| South Dakota | 3 | 1993 | 32 | 0.020 |
Why?
|
| Prenatal Care | 1 | 1996 | 1159 | 0.020 |
Why?
|
| Erectile Dysfunction | 1 | 2011 | 445 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 1996 | 1672 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 3631 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 14199 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 612 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 845 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 1273 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 180 | 0.020 |
Why?
|
| Likelihood Functions | 2 | 2001 | 993 | 0.020 |
Why?
|
| Yoga | 1 | 2011 | 280 | 0.020 |
Why?
|
| Carotid Stenosis | 1 | 1995 | 862 | 0.020 |
Why?
|
| Kaempferols | 1 | 2007 | 22 | 0.020 |
Why?
|
| Brain | 3 | 2019 | 27476 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1988 | 225 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 9564 | 0.020 |
Why?
|
| Hair Preparations | 1 | 1987 | 32 | 0.020 |
Why?
|
| Ketones | 1 | 2008 | 183 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 8559 | 0.020 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2008 | 124 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 1998 | 3216 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2014 | 1309 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 2 | 2004 | 868 | 0.020 |
Why?
|
| Molecular Sequence Data | 5 | 2000 | 17629 | 0.020 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 496 | 0.020 |
Why?
|
| Hydrogenation | 2 | 1999 | 20 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 1988 | 422 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2012 | 1148 | 0.020 |
Why?
|
| DNA Helicases | 1 | 2012 | 854 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1987 | 71 | 0.020 |
Why?
|
| Nevus, Pigmented | 1 | 1989 | 222 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 466 | 0.020 |
Why?
|
| Blood Viscosity | 1 | 1987 | 125 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2011 | 465 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 2 | 2011 | 1182 | 0.020 |
Why?
|
| Television | 2 | 2001 | 410 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1290 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2013 | 1757 | 0.020 |
Why?
|
| Canada | 2 | 2004 | 2129 | 0.020 |
Why?
|
| Running | 1 | 2011 | 490 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2011 | 697 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 501 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1769 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 558 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1972 | 3076 | 0.020 |
Why?
|
| Infusions, Parenteral | 2 | 1985 | 397 | 0.020 |
Why?
|
| Alcoholism | 3 | 2001 | 1981 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 811 | 0.020 |
Why?
|
| Colonoscopy | 4 | 1997 | 1410 | 0.020 |
Why?
|
| Nevus | 1 | 1988 | 205 | 0.020 |
Why?
|
| Calcifediol | 1 | 2007 | 160 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 598 | 0.020 |
Why?
|
| Electrolytes | 1 | 1987 | 279 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 1222 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2014 | 19023 | 0.020 |
Why?
|
| Abdomen | 2 | 2005 | 1137 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 1988 | 716 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 1647 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 847 | 0.020 |
Why?
|
| Science | 1 | 2008 | 236 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 859 | 0.020 |
Why?
|
| Calcitriol | 1 | 2007 | 303 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1437 | 0.020 |
Why?
|
| Veterinarians | 1 | 2005 | 13 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 7460 | 0.020 |
Why?
|
| Severity of Illness Index | 4 | 2008 | 15955 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4291 | 0.020 |
Why?
|
| Chromium Compounds | 1 | 2004 | 7 | 0.010 |
Why?
|
| Diploidy | 1 | 1985 | 140 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2008 | 1990 | 0.010 |
Why?
|
| Albumins | 1 | 2007 | 577 | 0.010 |
Why?
|
| Asia, Southeastern | 1 | 2004 | 115 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1705 | 0.010 |
Why?
|
| Patient Selection | 2 | 2009 | 4265 | 0.010 |
Why?
|
| Heart | 4 | 1972 | 4448 | 0.010 |
Why?
|
| Apoprotein(a) | 1 | 2004 | 17 | 0.010 |
Why?
|
| Manufactured Materials | 1 | 2004 | 18 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1985 | 324 | 0.010 |
Why?
|
| Leisure Activities | 1 | 2006 | 310 | 0.010 |
Why?
|
| Hemodynamics | 4 | 1972 | 4199 | 0.010 |
Why?
|
| Phenols | 1 | 2008 | 523 | 0.010 |
Why?
|
| Mineral Fibers | 1 | 2004 | 26 | 0.010 |
Why?
|
| Oxygen Consumption | 6 | 1986 | 1883 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1642 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 1627 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3102 | 0.010 |
Why?
|
| Hospital Records | 1 | 2004 | 93 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2013 | 1421 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1984 | 292 | 0.010 |
Why?
|
| Myocardial Revascularization | 2 | 1998 | 796 | 0.010 |
Why?
|
| gamma-Tocopherol | 1 | 2003 | 29 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 1880 | 0.010 |
Why?
|
| Thiolester Hydrolases | 1 | 1984 | 91 | 0.010 |
Why?
|
| Cooking | 1 | 2006 | 314 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1972 | 2885 | 0.010 |
Why?
|
| Culture Media | 2 | 1989 | 898 | 0.010 |
Why?
|
| Thiamine | 1 | 2004 | 160 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2007 | 1609 | 0.010 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 1998 | 1243 | 0.010 |
Why?
|
| Freezing | 1 | 1984 | 311 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 2004 | 0.010 |
Why?
|
| Cell Line | 5 | 1989 | 15603 | 0.010 |
Why?
|
| Colon | 1 | 2011 | 1804 | 0.010 |
Why?
|
| Nitriles | 1 | 2008 | 990 | 0.010 |
Why?
|
| Physician's Role | 1 | 1989 | 926 | 0.010 |
Why?
|
| E-Selectin | 1 | 2005 | 578 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1505 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18366 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2663 | 0.010 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 692 | 0.010 |
Why?
|
| Pharmacists | 1 | 2005 | 261 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2005 | 594 | 0.010 |
Why?
|
| DNA Transposable Elements | 2 | 1997 | 764 | 0.010 |
Why?
|
| Electric Wiring | 1 | 2001 | 3 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 2525 | 0.010 |
Why?
|
| Methylation | 2 | 1996 | 1078 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2010 | 6001 | 0.010 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2002 | 99 | 0.010 |
Why?
|
| Proteinuria | 1 | 1984 | 610 | 0.010 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2001 | 28 | 0.010 |
Why?
|
| Cadmium | 1 | 2002 | 217 | 0.010 |
Why?
|
| Homocystine | 1 | 2001 | 21 | 0.010 |
Why?
|
| Geography | 1 | 2003 | 654 | 0.010 |
Why?
|
| Chlorides | 1 | 2004 | 666 | 0.010 |
Why?
|
| Reference Standards | 1 | 2005 | 1014 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p19 | 1 | 2000 | 12 | 0.010 |
Why?
|
| Disease Susceptibility | 2 | 1998 | 1794 | 0.010 |
Why?
|
| Codon | 1 | 2003 | 599 | 0.010 |
Why?
|
| Diazepam | 1 | 2002 | 214 | 0.010 |
Why?
|
| Chemoprevention | 1 | 2003 | 326 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2000 | 53 | 0.010 |
Why?
|
| Genome | 1 | 2009 | 1752 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2006 | 1104 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 2001 | 164 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 2004 | 737 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 2395 | 0.010 |
Why?
|
| Radiography | 2 | 1991 | 6991 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5035 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 2000 | 106 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2000 | 185 | 0.010 |
Why?
|
| Transfection | 1 | 2008 | 5763 | 0.010 |
Why?
|
| Pindolol | 1 | 1979 | 34 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2008 | 2771 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6525 | 0.010 |
Why?
|
| Family | 2 | 1993 | 3208 | 0.010 |
Why?
|
| Rats | 3 | 2001 | 23847 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 317 | 0.010 |
Why?
|
| Carotid Sinus | 2 | 1969 | 44 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2000 | 175 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3433 | 0.010 |
Why?
|
| Rats, Inbred SHR | 1 | 1999 | 186 | 0.010 |
Why?
|
| Collagen | 1 | 1988 | 2646 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2000 | 379 | 0.010 |
Why?
|
| Solubility | 1 | 2001 | 1087 | 0.010 |
Why?
|
| Bronchial Spasm | 1 | 1979 | 71 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2001 | 8200 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1714 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 2002 | 405 | 0.010 |
Why?
|
| Ouabain | 2 | 1970 | 246 | 0.010 |
Why?
|
| Mental Health | 1 | 2013 | 3275 | 0.010 |
Why?
|
| Memory | 1 | 2009 | 2210 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14485 | 0.010 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 1999 | 79 | 0.010 |
Why?
|
| Allied Health Personnel | 1 | 2000 | 156 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 2297 | 0.010 |
Why?
|
| Postal Service | 2 | 1990 | 96 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1993 | 3447 | 0.010 |
Why?
|
| Vascular Resistance | 4 | 1969 | 939 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1998 | 82 | 0.010 |
Why?
|
| 5,10-Methylenetetrahydrofolate Reductase (FADH2) | 1 | 1998 | 2 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2008 | 1789 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5905 | 0.010 |
Why?
|
| Cyclins | 1 | 2000 | 606 | 0.010 |
Why?
|
| Hemostasis | 1 | 2001 | 468 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5794 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4541 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1998 | 167 | 0.010 |
Why?
|
| Light | 1 | 1984 | 1356 | 0.010 |
Why?
|
| Propranolol | 1 | 1979 | 493 | 0.010 |
Why?
|
| Heart Rate | 8 | 1996 | 4217 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 4356 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2008 | 2029 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2000 | 354 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 1999 | 405 | 0.010 |
Why?
|
| Cocarcinogenesis | 1 | 1997 | 49 | 0.010 |
Why?
|
| Employment | 1 | 2004 | 1114 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2000 | 710 | 0.010 |
Why?
|
| Headache | 1 | 2005 | 1263 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1980 | 697 | 0.010 |
Why?
|
| Particle Size | 1 | 2001 | 1652 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 6805 | 0.010 |
Why?
|
| Nursing Staff | 1 | 1998 | 113 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 1890 | 0.010 |
Why?
|
| Tetrahydrofolates | 1 | 1997 | 58 | 0.010 |
Why?
|
| Protein C | 1 | 1997 | 134 | 0.010 |
Why?
|
| HELLP Syndrome | 1 | 1996 | 40 | 0.010 |
Why?
|
| Ovulation | 1 | 1997 | 181 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3274 | 0.010 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 1998 | 254 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2000 | 907 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1981 | 1616 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 2357 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 361 | 0.010 |
Why?
|
| Ulna Fractures | 1 | 1997 | 126 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1998 | 521 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2820 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1998 | 412 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2000 | 944 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 1998 | 305 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1073 | 0.010 |
Why?
|
| Herpes Simplex | 1 | 1998 | 470 | 0.010 |
Why?
|
| Accidents | 1 | 1996 | 164 | 0.010 |
Why?
|
| Infant | 2 | 2013 | 36541 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5342 | 0.010 |
Why?
|
| Anxiety | 1 | 2010 | 4677 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1998 | 931 | 0.010 |
Why?
|
| Immunoassay | 1 | 1998 | 746 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 765 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 42684 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1995 | 400 | 0.010 |
Why?
|
| Apolipoprotein A-II | 1 | 1993 | 41 | 0.010 |
Why?
|
| Chlorine | 1 | 1993 | 55 | 0.010 |
Why?
|
| Arteries | 2 | 1997 | 1126 | 0.010 |
Why?
|
| Urination Disorders | 1 | 1994 | 238 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2011 | 11684 | 0.010 |
Why?
|
| Decision Making | 1 | 2007 | 3952 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2009 | 3811 | 0.010 |
Why?
|
| Sulfur | 1 | 1993 | 158 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2000 | 1438 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1972 | 109 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1972 | 298 | 0.010 |
Why?
|
| Environmental Exposure | 2 | 1987 | 4538 | 0.010 |
Why?
|
| Cell Division | 1 | 1980 | 4478 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1972 | 111 | 0.010 |
Why?
|
| Counseling | 1 | 2000 | 1554 | 0.010 |
Why?
|
| Uridine | 1 | 1972 | 135 | 0.010 |
Why?
|
| Tritium | 1 | 1972 | 707 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1998 | 839 | 0.010 |
Why?
|
| Self Administration | 1 | 1993 | 388 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1980 | 1842 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 1972 | 637 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 3744 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1972 | 266 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1514 | 0.010 |
Why?
|
| Candy | 1 | 1991 | 36 | 0.010 |
Why?
|
| Funnel Chest | 1 | 1972 | 75 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1995 | 1154 | 0.010 |
Why?
|
| Photosensitivity Disorders | 1 | 1991 | 79 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1995 | 4042 | 0.010 |
Why?
|
| Digitalis Glycosides | 1 | 1970 | 47 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1972 | 1305 | 0.010 |
Why?
|
| Copper | 1 | 1993 | 369 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1993 | 727 | 0.010 |
Why?
|
| Biological Transport | 1 | 1995 | 2085 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1970 | 398 | 0.010 |
Why?
|
| Transaminases | 1 | 1991 | 199 | 0.010 |
Why?
|
| Cacao | 1 | 1991 | 98 | 0.010 |
Why?
|
| Electric Stimulation | 3 | 1970 | 1743 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2000 | 2714 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1991 | 615 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1997 | 2920 | 0.010 |
Why?
|
| Arsenic | 1 | 1993 | 358 | 0.010 |
Why?
|
| DNA Replication | 1 | 1997 | 1428 | 0.010 |
Why?
|
| Soil | 1 | 1990 | 120 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1980 | 4178 | 0.010 |
Why?
|
| Rest | 3 | 1969 | 951 | 0.010 |
Why?
|
| Bacteriophages | 1 | 1972 | 382 | 0.010 |
Why?
|
| Exercise Test | 4 | 1972 | 2187 | 0.000 |
Why?
|
| Myocardium | 3 | 1999 | 4790 | 0.000 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3253 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13427 | 0.000 |
Why?
|
| Acute Disease | 1 | 1999 | 7245 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1989 | 699 | 0.000 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 867 | 0.000 |
Why?
|
| Proto-Oncogenes | 1 | 1988 | 322 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1972 | 1505 | 0.000 |
Why?
|
| Castration | 1 | 1987 | 150 | 0.000 |
Why?
|
| Cholera Toxin | 1 | 1989 | 562 | 0.000 |
Why?
|
| Rheumatic Heart Disease | 1 | 1968 | 164 | 0.000 |
Why?
|
| Pulmonary Artery | 3 | 1972 | 1945 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1996 | 6320 | 0.000 |
Why?
|
| Osteoporosis | 1 | 1996 | 1606 | 0.000 |
Why?
|
| Bradycardia | 1 | 1968 | 305 | 0.000 |
Why?
|
| Skin | 2 | 1993 | 4507 | 0.000 |
Why?
|
| Mitral Valve Stenosis | 1 | 1968 | 342 | 0.000 |
Why?
|
| Cyclic AMP | 1 | 1989 | 1470 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 1629 | 0.000 |
Why?
|
| Kinetics | 1 | 1993 | 6334 | 0.000 |
Why?
|
| Pain | 1 | 2000 | 5100 | 0.000 |
Why?
|
| Syncope | 1 | 1968 | 430 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1969 | 791 | 0.000 |
Why?
|
| Self Concept | 1 | 1990 | 1046 | 0.000 |
Why?
|
| Clinical Enzyme Tests | 1 | 1984 | 114 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1990 | 1669 | 0.000 |
Why?
|
| Leg | 1 | 1989 | 1089 | 0.000 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2000 | 5707 | 0.000 |
Why?
|
| RNA, Viral | 1 | 1972 | 2871 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1988 | 1099 | 0.000 |
Why?
|
| Acetylation | 1 | 1986 | 1056 | 0.000 |
Why?
|
| Heart Failure | 1 | 1968 | 11879 | 0.000 |
Why?
|
| Coronary Care Units | 1 | 1985 | 235 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 2914 | 0.000 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1984 | 103 | 0.000 |
Why?
|
| Diterpenes | 1 | 1983 | 170 | 0.000 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5434 | 0.000 |
Why?
|
| Extremities | 1 | 1988 | 870 | 0.000 |
Why?
|
| Respiratory Function Tests | 2 | 1979 | 1695 | 0.000 |
Why?
|
| Oxygen | 2 | 1972 | 4273 | 0.000 |
Why?
|
| Adenosine Triphosphate | 1 | 1985 | 2003 | 0.000 |
Why?
|
| Cytological Techniques | 1 | 1981 | 218 | 0.000 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1981 | 694 | 0.000 |
Why?
|
| Chromosome Aberrations | 1 | 1985 | 1780 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1979 | 1379 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1979 | 997 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1981 | 2475 | 0.000 |
Why?
|
| Blood Flow Velocity | 2 | 1970 | 1376 | 0.000 |
Why?
|
| Cardiomyopathies | 1 | 1968 | 2057 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1987 | 1941 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1983 | 957 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1979 | 1832 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1985 | 3124 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1997 | 20776 | 0.000 |
Why?
|
| Phonocardiography | 1 | 1972 | 30 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1981 | 2937 | 0.000 |
Why?
|
| Respiration | 2 | 1969 | 1668 | 0.000 |
Why?
|
| Anticoagulants | 1 | 1985 | 4850 | 0.000 |
Why?
|
| Pressoreceptors | 1 | 1969 | 99 | 0.000 |
Why?
|
| Methods | 1 | 1969 | 1066 | 0.000 |
Why?
|
| Ventricular Fibrillation | 1 | 1970 | 537 | 0.000 |
Why?
|
| Reflex | 1 | 1969 | 375 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1970 | 1762 | 0.000 |
Why?
|
| Dogs | 1 | 1970 | 3845 | 0.000 |
Why?
|
| Forearm | 1 | 1968 | 428 | 0.000 |
Why?
|
| Hypotension, Orthostatic | 1 | 1968 | 258 | 0.000 |
Why?
|
| Oximetry | 1 | 1967 | 462 | 0.000 |
Why?
|
| Veins | 1 | 1968 | 769 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1969 | 1345 | 0.000 |
Why?
|
| Lung | 1 | 1972 | 10097 | 0.000 |
Why?
|
| Atrial Fibrillation | 1 | 1968 | 5176 | 0.000 |
Why?
|